LA Improves the Prognosis of Patients With ICVD

NANot yet recruitingINTERVENTIONAL
Enrollment

236

Participants

Timeline

Start Date

May 4, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2028

Conditions
IschemiaCerebrovascular IschemiaCognitive Impairment
Interventions
DIETARY_SUPPLEMENT

Lactobacillus acidophilus

Lactobacillus acidophilus solid drink (pure bacteria, food grade, JYLA-191, Shandong Zhongke Jia-yi Biological Engineering Co., LTD.), 3g (containing 2\*10\^10CFU), twice a day, once in the morning and once in the evening, 1 bag each time, by drinking water, direct oral intake, 1 month/course, continuous use for three courses.

DIETARY_SUPPLEMENT

Maltodextrin

Maltodextrin solid drink (food grade, MD20, Shandong Zhongke Jia-yi Biological Engineering Co., LTD.), 3g, twice a day, once in the morning and once in the evening, 1 bag each time, by drinking water, direct oral intake, 1 month/course, continuous use for three courses.

All Listed Sponsors
lead

Huaqiu Zhang

OTHER

NCT05845983 - LA Improves the Prognosis of Patients With ICVD | Biotech Hunter | Biotech Hunter